Variant report
Variant | esv1007585 |
---|---|
Chromosome Location | chr1:214962973-214966701 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188025887 | chr1:214965030-214965031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566624337 | chr1:214965085-214965086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538790991 | chr1:214965088-214965089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2154119 | chr1:214965101-214965102 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs373715657 | chr1:214965123-214965124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2032042 | chr1:214965192-214965193 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs2032043 | chr1:214965235-214965236 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs112352904 | chr1:214965253-214965254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554931038 | chr1:214965254-214965255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575239611 | chr1:214965269-214965270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191105033 | chr1:214965332-214965333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553044361 | chr1:214965451-214965452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1450601 | chr1:214965457-214965458 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs544729644 | chr1:214965467-214965468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12022628 | chr1:214965475-214965476 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs12063597 | chr1:214965513-214965514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544427320 | chr1:214965529-214965530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374561576 | chr1:214965556-214965557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182266993 | chr1:214965597-214965598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562683356 | chr1:214965619-214965620 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75041647 | chr1:214965653-214965654 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546582448 | chr1:214965656-214965657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560076845 | chr1:214965663-214965664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142699525 | chr1:214965664-214965665 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1450600 | chr1:214965677-214965678 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs114372394 | chr1:214965739-214965740 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75005876 | chr1:214965762-214965763 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548810029 | chr1:214965784-214965785 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568760293 | chr1:214965791-214965792 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs187586349 | chr1:214965864-214965865 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192421865 | chr1:214965883-214965884 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1450599 | chr1:214965896-214965897 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs1779685 | chr1:214966001-214966002 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560265438 | chr1:214966024-214966025 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558351311 | chr1:214966060-214966061 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34041000 | chr1:214966106-214966107 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34279103 | chr1:214966126-214966127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185653469 | chr1:214966148-214966149 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544075684 | chr1:214966172-214966173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145996977 | chr1:214966208-214966209 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574303688 | chr1:214966258-214966259 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549742246 | chr1:214966265-214966266 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540091410 | chr1:214966269-214966270 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs139594865 | chr1:214966302-214966303 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560038264 | chr1:214966423-214966424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532370304 | chr1:214966435-214966436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190226703 | chr1:214966447-214966448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149298588 | chr1:214966478-214966479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531873562 | chr1:214966487-214966488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144474401 | chr1:214966575-214966576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:214965000-214966600 | Enhancers | Osteobl | bone |
2 | chr1:214965200-214965800 | Enhancers | Placenta Amnion | Placenta Amnion |
3 | chr1:214965200-214966000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
4 | chr1:214965200-214967000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr1:214965200-214967400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr1:214965400-214965600 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr1:214965400-214966400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr1:214965600-214966400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
9 | chr1:214966000-214967000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr1:214966000-214967200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr1:214966400-214967200 | Enhancers | Muscle Satellite Cultured Cells | -- |